45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
●Min / max negotiated charges: assessment threshold met
●Free, public, no login required: assessment threshold met
Procedures listed
15,088
Insurances with rates
16
CPT / HCPCS codes
11,703
Most expensive procedures (gross)
J0225
$233,666
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$744,578
J0225
$233,666
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$744,578
J1303
$125,377
RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION
Gross
$399,514
J1303
$125,377
RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION
Gross
$399,514
90378
$91,976
PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION
Gross
$293,083
90378
$91,976
PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION
Gross
$293,083
J0285
$91,032
AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE)
Gross
$290,074
J0285
$91,032
AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE)
Gross
$290,074
C1877
$77,969
THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A
Gross
$248,448
C1877
$77,969
THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A
Gross
$248,448
C1882
$58,802
ACTICOR 7 HF-T 429523
Gross
$187,374
C1882
$58,802
ACTICOR 7 HF-T 429523
Gross
$187,374
J2020
$55,517
LINEZOLID 2 MG/ML IV SYRINGE (NEONATE)
Gross
$176,905
J2020
$55,517
LINEZOLID 2 MG/ML IV SYRINGE (NEONATE)
Gross
$176,905
C1605
$53,464
PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR
Gross
$170,364
C1605
$53,464
PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR
Gross
$170,364
C1824
$51,236
OPTIMIZER SMART IPG 10-B411-3-XX
Gross
$163,266
C1824
$51,236
OPTIMIZER SMART IPG 10-B411-3-XX
Gross
$163,266
J1747
$51,056
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$162,690
J1747
$51,056
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$162,690
C1820
$49,009
KT IMP VERCISE GEVIA GENRTR M365DB1200S0
Gross
$156,167
C1820
$49,009
KT IMP VERCISE GEVIA GENRTR M365DB1200S0
Gross
$156,167
C1826
$49,009
NEUROSTIMULATOR RECHRG 977119
Gross
$156,167
C1826
$49,009
NEUROSTIMULATOR RECHRG 977119
Gross
$156,167
J9266
$48,846
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$155,647
J9266
$48,846
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$155,647
C1767
$47,995
DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX
Gross
$152,937
C1767
$47,995
DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX
Gross
$152,937
C2624
$46,781
SYS DEL PA SENS CARDIOMEMS CM2000
Gross
$149,069
C2624
$46,781
SYS DEL PA SENS CARDIOMEMS CM2000
Gross
$149,069
J9228
$46,123
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$146,973
J9228
$46,123
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$146,973
J9359
$46,008
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$146,606
J9359
$46,008
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$146,606
J0222
$44,266
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$141,054
J0222
$44,266
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$141,054
C2616
$39,541
THERASPHERE Y-90 1-20GBQ Y90THERA
Gross
$125,998
C2616
$39,541
THERASPHERE Y-90 1-20GBQ Y90THERA
Gross
$125,998
J9229
$38,929
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$124,046
J9229
$38,929
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$124,046
C1787
$36,311
KT PULSE GEN 16 WAVEWRITER ALP M365SC12160
Gross
$115,706
C1787
$36,311
KT PULSE GEN 16 WAVEWRITER ALP M365SC12160
Gross
$115,706
77371
$35,975
HC SRS CMPL MS GAMMA KNIFE TMT
Gross
$114,636
77371
$35,975
HC SRS CMPL MS GAMMA KNIFE TMT
Gross
$114,636
J9350
$35,955
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$114,570
J9350
$35,955
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$114,570
C1822
$35,643
IPG W/KIT NIPG1500
Gross
$113,576
C1822
$35,643
IPG W/KIT NIPG1500
Gross
$113,576
L8614
$34,883
IMP COCHLEAR MODEL CI624 O P1431676
Gross
$111,154
L8614
$34,883
IMP COCHLEAR MODEL CI624 O P1431676
Gross
$111,154
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $744,578 | $233,666 | $409,518 | $558,434 | 4 |
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $744,578 | $233,666 | $372,289 | $558,434 | 3 |
| J1303 | RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION | $399,514 | $125,377 | $219,733 | $299,636 | 4 |
| J1303 | RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION | $399,514 | $125,377 | $221 | $299,636 | 29 |
| 90378 | PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION | $293,083 | $91,976 | $161,196 | $219,812 | 4 |
| 90378 | PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION | $293,083 | $91,976 | $340 | $219,812 | 30 |
| J0285 | AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE) | $290,074 | $91,032 | $159,541 | $217,556 | 4 |
| J0285 | AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE) | $290,074 | $91,032 | $145,037 | $217,556 | 3 |
| C1877 | THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A | $248,448 | $77,969 | $136,646 | $186,336 | 3 |
| C1877 | THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A | $248,448 | $77,969 | $124,224 | $186,336 | 3 |
| C1882 | ACTICOR 7 HF-T 429523 | $187,374 | $58,802 | $131,162 | $140,531 | 3 |
| C1882 | ACTICOR 7 HF-T 429523 | $187,374 | $58,802 | $93,687 | $140,531 | 3 |
| J2020 | LINEZOLID 2 MG/ML IV SYRINGE (NEONATE) | $176,905 | $55,517 | $97,298 | $132,679 | 4 |
| J2020 | LINEZOLID 2 MG/ML IV SYRINGE (NEONATE) | $176,905 | $55,517 | $146 | $132,679 | 4 |
| C1605 | PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR | $170,364 | $53,464 | $119,255 | $127,773 | 3 |
| C1605 | PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR | $170,364 | $53,464 | $85,182 | $127,773 | 3 |
| C1824 | OPTIMIZER SMART IPG 10-B411-3-XX | $163,266 | $51,236 | $89,796 | $122,449 | 3 |
| C1824 | OPTIMIZER SMART IPG 10-B411-3-XX | $163,266 | $51,236 | $81,633 | $122,449 | 3 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $162,690 | $51,056 | $89,480 | $122,018 | 4 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $162,690 | $51,056 | $81,345 | $122,018 | 3 |
| C1820 | KT IMP VERCISE GEVIA GENRTR M365DB1200S0 | $156,167 | $49,009 | $85,892 | $117,125 | 3 |
| C1820 | KT IMP VERCISE GEVIA GENRTR M365DB1200S0 | $156,167 | $49,009 | $78,084 | $117,125 | 3 |
| C1826 | NEUROSTIMULATOR RECHRG 977119 | $156,167 | $49,009 | $85,892 | $117,125 | 3 |
| C1826 | NEUROSTIMULATOR RECHRG 977119 | $156,167 | $49,009 | $78,084 | $117,125 | 3 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $155,647 | $48,846 | $85,606 | $116,735 | 4 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $155,647 | $48,846 | $11,049 | $135,004 | 30 |
| C1767 | DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX | $152,937 | $47,995 | $84,115 | $114,703 | 3 |
| C1767 | DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX | $152,937 | $47,995 | $76,469 | $114,703 | 3 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $149,069 | $46,781 | $81,988 | $111,801 | 3 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $149,069 | $46,781 | $74,534 | $111,801 | 3 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $146,973 | $46,123 | $80,835 | $110,230 | 4 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $146,973 | $46,123 | $172 | $110,230 | 30 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $146,606 | $46,008 | $80,633 | $109,955 | 4 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $146,606 | $46,008 | $73,303 | $109,955 | 3 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $141,054 | $44,266 | $77,580 | $105,791 | 4 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $141,054 | $44,266 | $98.83 | $105,791 | 29 |
| C2616 | THERASPHERE Y-90 1-20GBQ Y90THERA | $125,998 | $39,541 | $69,299 | $94,499 | 3 |
| C2616 | THERASPHERE Y-90 1-20GBQ Y90THERA | $125,998 | $39,541 | $19,462 | $94,499 | 30 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $124,046 | $38,929 | $68,225 | $93,035 | 4 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $124,046 | $38,929 | $2,580 | $93,035 | 29 |
| C1787 | KT PULSE GEN 16 WAVEWRITER ALP M365SC12160 | $115,706 | $36,311 | $63,638 | $86,779 | 3 |
| C1787 | KT PULSE GEN 16 WAVEWRITER ALP M365SC12160 | $115,706 | $36,311 | $57,853 | $86,779 | 3 |
| 77371 | HC SRS CMPL MS GAMMA KNIFE TMT | $114,636 | $35,975 | $82,538 | $85,977 | 2 |
| 77371 | HC SRS CMPL MS GAMMA KNIFE TMT | $114,636 | $35,975 | $8,509 | $85,977 | 30 |
| J9350 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $114,570 | $35,955 | $63,014 | $85,928 | 4 |
| J9350 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $114,570 | $35,955 | $57,285 | $85,928 | 3 |
| C1822 | IPG W/KIT NIPG1500 | $113,576 | $35,643 | $62,467 | $85,182 | 3 |
| C1822 | IPG W/KIT NIPG1500 | $113,576 | $35,643 | $56,788 | $85,182 | 3 |
| L8614 | IMP COCHLEAR MODEL CI624 O P1431676 | $111,154 | $34,883 | $61,135 | $83,365 | 3 |
| L8614 | IMP COCHLEAR MODEL CI624 O P1431676 | $111,154 | $34,883 | $55,577 | $83,365 | 3 |
Showing top 50 of 15,088 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.